A New Standard of Care in Rib Fixation

Supported by an unrestricted educational grant from Zimmer Biomet.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Analyze and apply the latest clinical study data on the use of surgical stabilization of rib fractures (SSRF).
• Compare the patient benefits of SSRF compared with conventional treatment modalities, including length of hospital stay, tracheostomies, thoracic deformity, pulmonary function, and return to prefracture activities.
• Discuss the health care-related economics of SSRF compared with conventional treatment modalities.

   

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Non-traditional program has been approved for 1.0 contact hour(s) Continuing Respiratory Care Education
(CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063
[Expired April 2022]

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
-Internet Explorer 11 for Windows
-Edge (recent versions; Chromium-based) for Windows
-Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
-Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
-Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements: -4GB+ RAM -Recommended internet speed 5Mbps+

Faculty and Disclosures

DISCLOSURE POLICY

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Sebastian D. Schubl, MD, FACS has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Zimmer Biomet.

Zachary M. Bauman, DO, MHA has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Zimmer Biomet.

The Evolve staff and planners have no financial relationships with commercial interests.

Justin C. Muste, MD, peer reviewer, has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Zimmer Biomet.